Maravai LifeSciences
MRVI
#5427
Rank
NZ$2.29 B
Marketcap
NZ$6.25
Share price
-2.43%
Change (1 day)
-32.75%
Change (1 year)

Operating Margin for Maravai LifeSciences (MRVI)

Operating Margin as of December 2025 (TTM): -113.61%

According to Maravai LifeSciences 's latest financial reports and stock price the company's current Operating Margin is -113.61%. At the end of 2024 the company had an Operating Margin of -100.89%.

Operating Margin history for Maravai LifeSciences from 2020 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-100.89%-147.19%
2023213.79%242.31%
202262.45%-5.95%
202166.41%130.94%
202028.76%-803.26%
2019-4.09%-69.31%
2018-13.32%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Novocure
NVCR
-19.77%-82.60% Jersey
Novavax
NVAX
-25.89%-77.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
-1,726.38% 1,419.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-129.00% 13.55%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.